Normal or stress-induced fibroblast senescence involves COX-2 activity.
Cyclooxygenase-2 (COX-2) is an inducible enzyme of the prostaglandin biosynthesis pathway. It is involved in many stress responses, and its activity can produce oxidative damage, suggesting it could participate in senescence. In this study, COX-2 expression is shown to increase during senescence of normal human dermal or prostatic fibroblasts, and the ensuing prostaglandin E(2) (PGE(2)) production to increase about 10-fold. Enhancing this COX-2 activity by supplying exogenous arachidonic acid accelerates the occurrence of the major markers of senescence, cell-size increase, spreading, senescence-associated-beta-galactosidase (SA-beta-Gal) activity and growth plateau. Conversely, blocking this COX-2 activity with the specific inhibitor NS398 partially inhibited the occurrence of these markers. COX-2 expression and PGE(2) production are also increased about 10-fold during both NF-kappaB- or H(2)O(2)-induced senescence. Using NS398 or small interferent RNA specifically targeting COX-2 attenuated the appearance of the SA-beta-Gal activity and growth arrest in both stress situations. Taken together, these findings indicate that COX-2 is highly up-regulated during both normal and stress-induced fibroblast senescence and contributes to the establishment of the senescent characteristics.
Zdanov
Stéphanie
S
Research Unit on Cellular Biology (URBC), University of Namur (FUNDP), rue de Bruxelles, 61 B-5000 Namur, Belgium.
Bernard
David
D
Debacq-Chainiaux
Florence
F
Martien
Sébastien
S
Gosselin
Karo
K
Vercamer
Chantal
C
Chelli
Fazia
F
Toussaint
Olivier
O
Abbadie
Corinne
C
D000818:Animals; D002478:Cells, Cultured; D016922:Cellular Senescence / Q000502:physiology*; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000502:physiology*; D020868:Gene Silencing; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D009578:Nitrobenzenes / Q000378:metabolism; D016877:Oxidants / Q000378:metabolism; D018384:Oxidative Stress; D020569:Proto-Oncogene Proteins c-rel / Q000235:genetics / Q000378:metabolism; D013449:Sulfonamides / Q000378:metabolism
D016861:Cyclooxygenase Inhibitors; D016328:NF-kappa B; D009578:Nitrobenzenes; D016877:Oxidants; D020569:Proto-Oncogene Proteins c-rel; D013449:Sulfonamides; C080955:N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; D006861:Hydrogen Peroxide; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D015232:Dinoprostone